Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-κB activator

Biochemical and Biophysical Research Communications

Volumn 410, Issue 2, 2011, Pages 247-251

  Yu, Shanshan ^a   Gao, Bo ^a   Duan, Zhijian ^a   Xu, Wei ^a   Xiong, Sidong ^a,b  

^a FUDAN UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

NF B; PDTC; Pro inflammatory cytokine; TRIM22

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; REGULATOR PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TRIPARTITE MOTIF CONTAINING 22 PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION;

ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; GENES, REPORTER; HEK293 CELLS; HUMANS; NF-KAPPA B; REPRESSOR PROTEINS; RING FINGER DOMAINS; TRANSCRIPTION, GENETIC; U937 CELLS;

EID: 79959753525     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.05.124     Document Type: Article

References (36)

1. Reymond A., Meroni G., Fantozzi A., et al. The tripartite motif family identifies cell compartments. EMBO J. 2001, 20:2140-2151.
2. Stremlau M., Owens C.M., Perron M.J., et al. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature 2004, 427:848-853.
3. Chelbi-Alix M.K., Quignon F., Pelicano L., et al. Resistance to virus Infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol. 1998, 72:1043-1051.
4. Barr S.D., Smiley J.R., Bushman F.D., et al. The interferon response inhibits HIV particle production by induction of TRIM22. PLoS Pathog. 2008, 4:e1000007.
5. Gao B., Duan Z., Xu W., et al. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain. Hepatology 2009, 50:424-433.
6. Wolf D., Hug K., Goff S.P. TRIM28 mediates primer binding site-targeted silencing of Lys1,2 tRNA-utilizing retroviruses in embryonic cells. Proc. Natl. Acad. Sci. USA 2008, 105:12521-12526.
7. McNab F.W., Rajsbaum R., Stoye J.P., O'Garra A. Tripartite-motif proteins and innate immune regulation. Curr. Opin. Immunol. 2011, 23:46-56.
8. Gack M.U., Shin Y.C., Joo C.H., et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446:916-920.
9. Yang K., Shi H.X., Liu X.Y., et al. TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response. J. Immunol. 2009, 182:3782-3792.
10. Kong H.J., Anderson D.E., Lee C.H., et al. Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages. J. Immunol. 2007, 179:26-30.
11. Wu W.S., Xu Z.X., Hittelman W.N., et al. Promyelocytic leukemia protein sensitizes tumor necrosis factor alpha-induced apoptosis by inhibiting the NF-kappaB survival pathway. J. Biol. Chem. 2003, 278:12294-12304.
12. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2002, 2:725-734.
13. Foletta V.C., Segal D.H., Cohen D.R. Transcriptional regulation in the immune system: all roads lead to AP-1. J. Leukoc. Biol. 1998, 63:139-152.
14. Kuklina E.M., Shirshev S.V. Role of transcription factor NFAT in the immune response. Biochemistry (Mosc) 2001, 66:467-475.
15. Wedel A., Ziegler-Heitbrock H.W. The C/EBP family of transcription factors. Immunobiology 1995, 193:171-185.
16. Taniguchi T., Ogasawara K., Takaoka A., et al. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 2001, 19:623-655.
17. Liu S., Chen Z.J. Expanding role of ubiquitination in NF-kappaB signaling. Cell Res. 2011, 21:6-21.
18. Duan Z., Gao B., Xu W., et al. Identification of TRIM22 as a RING finger E3 ubiquitin ligase. Biochem. Biophys. Res. Commun. 2008, 374:502-506.
19. Eldin P., Papon L., Oteiza A., et al. TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus. J. Gen. Virol. 2009, 90:536-545.
20. Deng Y.J., Huang Z.X., Zhou C.J., et al. Gene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus. Mol. Immunol. 2006, 43:1497-1507.
21. Gao B., Wang Y., Xu W., et al. A 5′ extended IFN-stimulating response element is crucial for IFN-gamma-induced tripartite motif 22 expression via interaction with IFN regulatory factor-1. J. Immunol. 2010, 185:2314-2323.
22. Wang Z.Y., Sato H., Kusam S., et al. Regulation of IL-10 gene expression in Th2 cells by Jun proteins. J. Immunol. 2005, 174:2098-2105.
23. Im S.H., Hueber A., Monticelli S., et al. Chromatin-level regulation of the IL10 gene in T cells. J. Biol. Chem. 2004, 279:46818-46825.
24. Lee C.G., Hwang W., Maeng K.E., et al. IRF4 regulates IL-10 gene expression in CD4(+) T cells through differential nuclear translocation. Cell. Immunol. 2011, 268:97-104.
25. Yoshimi R., Chang T.H., Wang H., et al. Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts. J. Immunol. 2009, 182:7527-7538.
26. Poole E., Groves I., MacDonald A., et al. Identification of TRIM23 as a cofactor involved in the regulation of NF-kappaB by human cytomegalovirus. J. Virol. 2009, 83:3581-3590.
27. Shi M., Deng W., Bi E., et al. TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat. Immunol. 2008, 9:369-377.
28. Wang Y., Li Y., Qi X., et al. TRIM45, a novel human RBCC/TRIM protein, inhibits transcriptional activities of ElK-1 and AP-1. Biochem. Biophys. Res. Commun. 2004, 323:9-16.
29. Lo Y.H., Wu C.C., Shih H.M., et al. Selective activation of NFAT by promyelocytic leukemia protein. Oncogene 2008, 27:3821-3830.
30. Tagata Y., Yoshida H., Nguyen L.A., et al. Phosphorylation of PML is essential for activation of C/EBP epsilon and PU.1 to accelerate granulocytic differentiation. Leukemia 2008, 22:273-280.
31. Dendorfer U., Oettgen P., Libermann T.A. Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. Mol. Cell. Biol. 1994, 14:4443-4454.
32. Thomas R.S., Tymms M.J., McKinlay L.H., et al. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter. Oncogene 1997, 14:2845-2855.
33. Baeuerle P.A. Pro-inflammatory signaling: last pieces in the NF-kappaB puzzle. Curr. Biol. 1998, 8:19-22.
34. Jochum C., Voth R., Rossol S., et al. Immunosuppressive function of hepatitis B antigens in vitro: role of endoribonuclease V as one potential trans inactivator for cytokines in macrophages and human hepatoma cells. J. Virol. 1990, 64:1956-1963.
35. Kerr J.R., Cunniffe V.S., Kelleher P., et al. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis. J. Med. Virol. 2004, 74:147-155.
36. Avrâmescu C.S., Comânescu V., Popescu S.N., et al. Correlations among the serum levels of some interleukins and the histopathological aspects in chronic viral hepatitis C. Rom. J. Morphol. Embryol. 2008, 49:57-62.